ArticleThe Biochemical journal2026
Molecular dissection of the Cereibacter sphaeroides spheroidene monooxygenase.
Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In some purple phototrophic bacteria, the enzyme spheroidene monooxygenase (CrtA) catalyses the final step of carotenoid biosynthesis, introducing a keto group at the C2 position of spheroidene to produce spheroidenone. CrtA from the model purple bacterium Cereibacter (previously Rhodobacter) sphaeroides has a C-terminal extension consisting of a disordered, proline-rich sequence followed by a short region containing a significant proportion of glycine residues; the role of this extension is not understood. In addition to the accumulation of spheroidene, a C. sphaeroides ΔcrtA mutant generated in a previous study had a slower growth rate and made fewer photosynthetic complexes than the wild-type strain. We show here that these phenotypes are largely due to a polar effect of the crtA deletion on the downstream bchID bacteriochlorophyll biosynthesis genes. We generated a crtA mutant where bchID expression was not interrupted and used this background to test a series of CrtA C-terminal truncations to identify the minimal enzyme that retains spheroidene monooxygenase activity. Using structural modelling, we identify a histidine residue that acts as the axial ligand to a heme group required for spheroidene monooxygenase activity, and two threonine residues found proximal to the bound carotenoid. We show that the subtle photoheterotrophic growth phenotype of this new ΔcrtA mutant is due to the loss of the C-terminus of the enzyme rather than the altered carotenoid content of this strain. We further demonstrate that the C-terminal extension appears to mediate the association of CrtA with other membrane proteins, forming a range of high-molecular-mass complexes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.